| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -193 | 100% | $61.23 | -$11.8K |
| Net | -1 | -193 | -100% | -$11.8K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Jon P. Stonehouse | Director | $946K | Nov 13, 2025 | ||
| Christopher Whitten Bernard | PRESIDENT AND CHIEF EXECUTIVE OFFICER, Director | $0 | Nov 13, 2025 | ||
| Clive Meanwell | EXECUTIVE CHAIRMAN, Director | $0 | Nov 13, 2025 | ||
| Validae Health, L.P. | 10%+ Owner | $0 | Nov 11, 2025 | ||
| Steven Marso | Chief Medical Officer | $0 | Nov 13, 2025 | ||
| Kristina Burow | Director | $0 | Nov 13, 2025 | ||
| Brian Hubbard | Chief Scientific Officer | $0 | Nov 13, 2025 | ||
| Christopher Visioli | Chief Financial Officer | $0 | Nov 13, 2025 | ||
| Paul L. Berns | Director | $0 | Nov 13, 2025 | ||
| Population Health Partners GP, LLC | 10%+ Owner | $0 | Nov 13, 2025 | ||
| ARCH Venture Partners XII, LLC | Director, 10%+ Owner | $0 | Nov 13, 2025 | ||
| Fmr Llc | Other*, 10%+ Owner | $0 | -$11.8K | -100% | Nov 13, 2025 |
| Joshua Pinto | Director | $0 | Nov 13, 2025 | ||
| Matthew Lang | Chief Legal Officer | $0 | Nov 13, 2025 | ||
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10%+ Owner | Jan 30, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|